TY - JOUR
T1 - Aggregate travel vs. single trip assessment: Arguments for cumulative risk analysis
AU - Leder, Karin Sharona
AU - Chen, L H
AU - Wilson, Mary E
PY - 2012
Y1 - 2012
N2 - Vaccine recommendations for travellers are based on individual risk assessments of multiple factors,
most importantly the destination and duration of the impending trip. Many people undertake frequent
trips, but existing WHO, CDC and national advisory board recommendations do not explicitly consider
cumulative travel-associated risks. Given the period of protection provided by many vaccines, in particular
rabies, hepatitis A, hepatitis B and yellow fever vaccines, an aggregate multi-trip risk assessment
which views vaccines as an investment for future travel health may be more appropriate than separately
evaluating the risks for each trip.
AB - Vaccine recommendations for travellers are based on individual risk assessments of multiple factors,
most importantly the destination and duration of the impending trip. Many people undertake frequent
trips, but existing WHO, CDC and national advisory board recommendations do not explicitly consider
cumulative travel-associated risks. Given the period of protection provided by many vaccines, in particular
rabies, hepatitis A, hepatitis B and yellow fever vaccines, an aggregate multi-trip risk assessment
which views vaccines as an investment for future travel health may be more appropriate than separately
evaluating the risks for each trip.
UR - http://www.sciencedirect.com/science/article/pii/S0264410X11020949
U2 - 10.1016/j.vaccine.2011.12.133
DO - 10.1016/j.vaccine.2011.12.133
M3 - Article
VL - 30
SP - 2600
EP - 2604
JO - Vaccine
JF - Vaccine
SN - 0264-410X
IS - 15
ER -
